Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| American Academy of Pediatrics | OTHER |
Not provided
Not provided
Not provided
Not provided
Background:
Asthma affects nearly 10% of American children, and is a leading cause of pediatric emergency visits and hospitalizations. Clinical pathways are operational versions of practice guidelines aimed at the hospital management of common illnesses. Single-site studies of pediatric asthma pathways have shown significant improvements in quality of care.
Primary Objective:
To evaluate the effectiveness of clinical pathways for improving quality of care for children with asthma in a diverse, national sample of emergency department (ED) and hospital settings.
Primary Endpoints:
Study Design:
This project will be implemented through an established quality improvement collaborative of hospitals across the United States, the Value in Inpatient Pediatrics Network (part of the American Academy of Pediatrics). A cluster randomized design will be employed. Group 1 hospitals will receive a multifaceted implementation strategy that includes: 1) a pathway implementation toolkit, 2) local multidisciplinary champions in the ED and inpatient settings, 3) audit and feedback, 4) educational seminars, and 5) practice facilitation (via teleconference). Group 2 will receive the same intervention with the addition of a mobile app pathway tool.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pathway Intervention 1 | Experimental | Hospitals randomized to group 1 receive PIPA Intervention Bundle 1. |
|
| Pathway Intervention 2 | Experimental | Hospitals randomized to group 2 receive PIPA Intervention Bundle 2, which adds a mobile app. |
|
| Control | No Intervention | Hospitals are in the control arm (usual care) after January 2017 until active implementation begins, which includes 3-6 months of implementation preparation (identifying local multidisciplinary champions, educational sessions/webinars for local champions, one teleconference with an external practice facilitator). |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PIPA Intervention Bundle 1 | Behavioral | The PIPA intervention bundle 1 includes:
|
| Measure | Description | Time Frame |
|---|---|---|
| Hospital/Inpatient: Mean length of hospital stay | 1 year | |
| Emergency Department: Proportion of eligible children who receive systemic steroids within 60 minutes of ED arrival | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Hospital/Inpatient: Proportion of children with administration of bronchodilator via metered-dose inhaler early in hospitalization | 1 year | |
| Hospital/Inpatient: Proportion of children screened for secondhand tobacco smoke exposure | 1 year |
Not provided
Participant/Local champion Eligibility Criteria:
Inclusion Criteria:
Exclusion Criteria:
Patient/child eligibility criteria:
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sunitha V Kaiser, MD MSc | University of California, San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California | San Francisco | California | 94158 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| PIPA Intervention Bundle 2 | Behavioral | The PIPA intervention bundle 2 includes:
|
|
| Hospital/Inpatient: Proportion of children who screen positive for secondhand tobacco smoke exposure whose caregivers are referred to smoking cessation resources | 1 year |
| Hospital/Inpatient: Proportion of children prescribed antibiotics at hospital discharge | 1 year |
| Hospital/Inpatient: Proportion of children with emergency department visits or readmissions to the hospital within 7 days | 1 year |
| Hospital/Inpatient: Proportion of children transferred to a higher level of care | 1 year |
| Emergency Department: Proportion of children who get an asthma exacerbation severity assessment at ED triage | 1 year |
| Emergency Department: Proportion of children who have chest radiographs performed | 1 year |
| Emergency Department: Proportion of children admitted to the hospital | 1 year |
| Emergency Department: Proportion of children transferred to a higher level of care | 1 year |
| Emergency Department: Mean length of emergency department stay | 1 year |
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |